TipRanks
Innate Pharma SA (IPHYF)
OTHER OTC:IPHYF

Compare Innate Pharma SA (IPHYF) vs. Competitors

27 Followers

Comparison Results

Name
Price
Market Cap
P/E Ratio
Yearly Gain
Analyst Consensus
Analyst Price Target
Compare
Top Analysts' Price Target
Smart Score
Follow
Innate Pharma SA
$1.65
$183.10M
-2.78
-17.50%
―
Abivax SA
€99.95
€7.15B
-17.80
19.27%
1 Buy
0 Hold
0 Sell
Moderate Buy
Nanobiotix
€35.74
€1.48B
-25.35
111.85%
1 Buy
0 Hold
0 Sell
Moderate Buy
Transgene
€0.80
€211.49M
-4.37
-37.07%
―
OSE Immunotherapeutics SA
€3.22
€52.75M
-1.40
-59.73%
―
Cellectis SA
€3.10
€90.26M
-2.22
-57.15%
―

Performance Comparison

Ticker
Company Name
Price
Change
% Change
IPHYF
Innate Pharma SA
1.65
-0.35
-17.50%
FR:ABVX
Abivax SA
83.85
11.95
16.62%
FR:NANO
Nanobiotix
27.88
11.20
67.15%
FR:TNG
Transgene
0.73
-0.42
-36.52%
FR:OSE
OSE Immunotherapeutics SA
2.37
-4.39
-64.94%
FR:ALCLS
Cellectis SA
1.28
-1.08
-45.81%
Compare key indicators and discover each stock’s average analyst price target, as well as the latest recommendations by top Wall Street experts